Tempo Therapeutics, Inc.
Biotechnology company · San Diego, California, United States
Tempo Therapeutics, Inc. is a biotechnology company headquartered in San Diego, California, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $4.4 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $16 million sold in a notice filed in 2024.
Tempo Therapeutics at a glance
What does Tempo Therapeutics do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $4.4 million in total (2016 to 2021). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $16.3 million sold (2024).
Frequently asked questions about Tempo Therapeutics
Where is Tempo Therapeutics headquartered?
Tempo Therapeutics, Inc. is headquartered in San Diego, California, United States.
What does Tempo Therapeutics do?
Tempo Therapeutics, Inc. is a biotechnology company.
Similar companies
- Biolinq IncSan Diego, California, United States
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.